HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists?

AuthorsMarco Zuin, Carlo Cervellati, Gianluca Rigatelli, Giovanni Zuliani, Loris Roncon
JournalThrombosis research (Thromb Res) Vol. 208 Pg. 170-172 (12 2021) ISSN: 1879-2472 [Electronic] United States
PMID34801920 (Publication Type: Letter, Comment)
Chemical References
  • Interleukin-6
Topics
  • COVID-19
  • Humans
  • Interleukin-6
  • SARS-CoV-2
  • Venous Thromboembolism (drug therapy)
  • Venous Thrombosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: